The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 19 , ISSUE 4 ( 2018 ) > List of Articles


In vitro Antimicrobial Activity of Ocimum sanctum (Tulsi) Extract on Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis

Md Jalaluddin, Anisha Avijeeta, Ipsita Jayanti, Pooja M Rai, Rohit A Nair

Keywords : Aggregatibacter actinomycetemcomitans, Antimicrobial, Ocimum sanctum, Porphyromonas gingivalis

Citation Information : Jalaluddin M, Avijeeta A, Jayanti I, Rai PM, Nair RA. In vitro Antimicrobial Activity of Ocimum sanctum (Tulsi) Extract on Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis. J Contemp Dent Pract 2018; 19 (4):415-419.

DOI: 10.5005/jp-journals-10024-2276

License: CC BY-NC 3.0

Published Online: 01-04-2018

Copyright Statement:  Copyright © 2018; The Author(s).


Aim: The present study was conducted with an aim to assess the antimicrobial activity of Ocimum sanctum (tulsi) extract on Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis. Materials and methods: Tulsi extract with ethanol was prepared using cold extraction method in the present in vitro study. Various concentrations (2, 4, 6, and 8%) were then obtained by dilution with dimethylformamide. A 0.2% chlorhexidine served as the positive control, whereas the negative control was dimethylformamide. Zones of inhibition were measured, each for A. actinomycetemcomitans and P. gingivalis. For comparison within the group and between the study groups, one-way analysis of variance (ANOVA) and Tukey's post hoc tests were used. A statistical significance level of p < 0.05 was established. Results: The 8% concentration of the tulsi extract showed maximum zone of inhibition against A. actinomycetemcomitans and P. gingivalis (40.10 ± 0.90, 33.79 ± 1.82 mm), followed by the 6, 4, and 2% concentrations. The 0.2% chlorhexidine, which was the positive control, had 39.80 ± 1.24 and 32.28 ± 1.28 mm zones of inhibition; dimethylformamide showed 13.55 ± 1.92 and 10.21 ± 2.16 mm zones of inhibition against both the microorganisms. The ANOVA showed highly statistically significant (p < 0.0001) results between and within the groups. The antimicrobial activity of tulsi extract at 6 and 8% concentrations, and 0.2% chlorhexidine against A. actinomycetemcomitans showed statistically significant differences between the groups. The concentration of tulsi extract at 8 and 0.2% chlorhexidine on P. gingivalis showed statistically significant differences between the groups. Conclusion: It was concluded that 8% concentration of O. sanctum (tulsi) extract showed the maximum antimicrobial activity against A. actinomycetemcomitans and P. gingivalis. It is thus recommended that this may be useful as an adjunctive to mechanical therapy in the prevention and treatment of periodontal diseases. Clinical significance: O. sanctum (tulsi) is a herb that is abundantly available, easily accessible, economically feasible, and culturally acceptable. Therefore, it is very useful in the management of oral diseases and also for overcoming many barriers that exist for the utilization of dental services, such as affordability, accessibility, availability, and acceptability.

PDF Share
  1. Shah R, Gayathri GV, Mehta DS. Application of herbal products in management of periodontal diseases: a mini review. Int J Oral Health Sci 2015 Dec;5(1):38-44.
  2. van Winkelhoff AJ, Loos BG, van der Reijden WA, van der Velden U. Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogen in subjects with and without periodontal destruction. J Clin Periodontol 2002 Nov;29(11):1023-1028.
  3. Savita AM, Dawra C, Bhat K. An in vitro evaluation of antibacterial activity of curcumin against Aggregatibacter actinomycetemcomitans. World J Dent 2015 Jan-Mar;6(1):16-19.
  4. Teughels, W.; Quirynen, M.; Jakubovics, N. Periodontal microbiology. In: Newman MG, Takei HH, Klokkevold PR, Carranza FA, editors. Carranza's clinical periodontolgy. India: Elsevier Health Sciences; 2012. pp. 232-227.
  5. Pandit N, Changela R, Bali D, Tikoo P, Gugnani S. Porphyromonas gingivalis: its virulence and vaccine. J Int Clin Dent Res Organ 2015 Mar;7(1):51-58.
  6. Vishwakarma A. A review on antimicrobial potential of Indian Ocimum sanctum (Tulsi). Int J Sci Res 2017 May;6(5):1490-1492.
  7. Eswar P, Devaraj CG, Agarwal P. Anti-microbial activity of tulsi {Ocimum Sanctum (Linn.)} extract on a periodontal pathogen in human dental plaque: an in vitro study. J Clin Diagn Res 2016 Mar;10(3):ZC53-ZC56.
  8. Chandrashekar BR, Nagarajappa R, Singh R, Thakur R. An in vitro study on the anti-microbial efficacy of ten herbal extracts on primary plaque colonizers. J Young Pharm 2014 Aug;6(4):33-39.
  9. Ishikawa I. Host responses in periodontal diseases: a preview. Periodontol 2000 2007 Feb;43(1):9-13.
  10. Jorgensen MG, Slots J. The ins and outs of periodontal antimicrobial therapy. J Calif Dent Assoc 2002 Apr;30(4):297-305.
  11. Fine JB, Harper DS, Gordon JM, Hovliaras CA, Charles CH. Short-term microbiological and clinical effects of subgingival irrigation with an antimicrobial mouthrinse. J Periodontol 1994 Jan;65(1):30-36.
  12. Stingu CS, Jentsch H, Eick S, Schaumann R, Knöfler G, Rodloff A. Microbial profile of patients with periodontitis compared with healthy subjects. Quintessence Int 2012 Feb;43(2):e23-e31.
  13. Mallikarjun S, Rao A, Rajesh G, Shenoy R, Pai M. Antimicrobial efficacy of Tulsi leaf (Ocimum sanctum) extract on periodontal pathogens: an in vitro study. J Indian Soc Periodontol 2016 Mar-Apr;20(2):145-150.
  14. Vishwabhan S, Birendra VK, Vishal S, Gyan S. A review on ethnomedical uses of Ocimum sanctum (Tulsi). Int Res J Pharm 2011;2:1-3.
  15. Nahak G, Mishra RC, Sahu RK. Taxonomic distribution, medicinal properties and drug development potentiality of Ocimum (Tulsi). Drug Invent Today 2011 Jun;3(6):95-113.
  16. Singhal G, Bhavesh R, Kasariya K, Sharma AR, Singh RP. Biosynthesis of silver nanoparticles using Ocimum sanctum (Tulsi) leaf extract and screening its antimicrobial activity. J Nanopart Res 2011 Jul;13(7):2981-2988.
  17. Rathod GP, Kotecha BM, Sharma R, Amin H, Prajapati PK. In vitro antibacterial study of two commonly used medicinal plants in ayurveda neem Azadirachta indica L and Tulsi Ocimum sanctum L. Int J Pharm Biol 2012 Jul;3(3):582-586.
  18. Shah S, Trivedi B, Patel J, Dave JH, Sathvara N, Shah V. Evaluation and comparison of antimicrobial activity of Tulsi (Ocimum Sanctum), Neem (Azadirachta indica) and triphala extract against Streptococcus mutans & Lactobacillus acidophilus: an in vitro study. Natl J Int Res Med 2014 Jul;5(4):17-21.
  19. Prasannabalaji N, Muralitharan G, Sivanandan RN, Kumaran S, Pugazhvendan SR. Antibacterial activities of some Indian traditional plant extracts. Asian Pac J Trop Dis 2012 Dec;2 (Suppl 1):S291-S295.
  20. Bansal K, Rawat MK, Jain A, Rajput A, Chaturvedi TP, Singh S. Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS Pharm Sci Tech 2009 Sep;10(3):716-723.
  21. Gupta D, Bhaskar DJ, Gupta RK, Karim B, Jain A, Singh R, Karim W. A randomised controlled clinical trial of Ocimum sanctum and chlorhexidine mouthwash on dental plaque and gingival inflammation. J Ayurveda Integr Med 2014 Apr;5(2):109-116.
  22. Mistry KS, Sanghvi Z, Parmar G, Shah S. The antimicrobial activity of Azadirachta indica, Mimusops elengi, Tinospara cardifolia, Ocimim sanctum and 2% chlorhexidine gluconate on common endodontic pathogens: an in vitro study. Eur J Dent 2014 Apr;8(2):172-177.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.